| Mrs Alyssa Dawn Miller, SLP | |
|
21 Loch Lomond Rd, Livingston, MT 59047-8837 | |
| (406) 223-6771 | |
| Not Available |
| Full Name | Mrs Alyssa Dawn Miller |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 21 Loch Lomond Rd, Livingston, Montana |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114206489 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 1126 (Montana) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Alyssa Dawn Miller, SLP 21 Loch Lomond Rd, Livingston, MT 59047-8837 Ph: (406) 223-6771 | Mrs Alyssa Dawn Miller, SLP 21 Loch Lomond Rd, Livingston, MT 59047-8837 Ph: (406) 223-6771 |
News Archive
Young adults who suffer from posttraumatic stress disorder may be more likely to experience a transient ischemic attack or major stroke event by middle age, raising the risk as much as other better-known risk factors, according to new research published in Stroke, a journal of the American Stroke Association, a division of the American Heart Association.
Carnegie Mellon University, the University of Pittsburgh and UPMC (University of Pittsburgh Medical Center) have driven a dramatic shift in the Pittsburgh economy during the last four decades, transforming the city from a manufacturing town to an international knowledge-based center for research, education and medicine.
Protox Therapeutics Inc. (TSX: PRX), a leader in the development of receptor targeted fusion proteins, today announced that it has completed patient enrollment in its multi-centre, double-blinded, placebo controlled Phase 2b study of PRX302 (study name: TRIUMPH) in males with moderate to severe benign prostatic hyperplasia (BPH), a common and bothersome urological condition that affects more than 50 million men worldwide.
Valley Behavioral Health is launching a technology-based program to better understand a patient's health status and predict likely receptivity and compliance to treatment - all of which is designed to greatly improve healthcare services to its patients throughout its regional service area.
The spread of the coronavirus disease (COVID-19) has reached pandemic status, spanning 114 countries and territories, the World Health Organization (WHO) declared. The novel coronavirus that emerged three months ago has rapidly infected more than 126,000 people, taking the lives of more than 4,600.
› Verified 3 days ago
Jamie Lynn Van Zee, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 80 West Pine Creek, Livingston, MT 59047 Phone: 651-491-7977 | |
Miss Melissa Capocaccia, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Ms. Lisa Calkins Vanderpan, M.S., SLP-CCC Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 510 S 14th St, Livingston, MT 59047 Phone: 406-222-0672 | |
Arrowhead Elementary District #75 Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 1489 E River Rd, Livingston, MT 59047 Phone: 406-924-6865 Fax: 406-924-6865 | |
Mrs. Sheridan Cotrell, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21 Loch Lomond Rd, Livingston, MT 59047 Phone: 406-223-6763 | |
Mrs. Lisa Renee Banuelos-martin, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 601 Robin Ln, Livingston, MT 59047 Phone: 406-222-7231 Fax: 406-222-2435 |